Chief Research and Development Officer
BioCryst Pharmaceuticals, Inc.
Barbara Wirostko, MD
Chief Medical Officer & Co-Founder
The pandemic changed everything — requiring our PharmaVoice 100 honorees to pivot, be agile, develop new skills, and think about health equity and diversity in a different way. As the industry moves into a post-pandemic phase, there is no going back. The next era of leadership — from molecule to market — will be more focused on patients than ever before and ripe with opportunities for emerging science and talent.
Join PharmaVoice Editor in Chief Emeritus Taren Grom and industry leaders for a full-day event featuring engaging and interactive discussions with your peers and PharmaVoice 100 honorees, followed by a PharmaVoice 100 Celebration ceremony and more networking opportunities.
See below for more information on the sessions.
About PharmaVoice 100:
Our PharmaVoice publication developed the only awards program in the industry to recognize a diverse mix of people across a range of disciplines and ages — from the clinic to the C-suite — who are making meaningful contributions in their fields of influence. Since 2005, the PharmaVoice 100-- and Red Jacket honorees- have become one of the publication’s most anticipated features, and are determined by nominations submitted from colleagues and peers in the industry.
Event Powered By
Welcome and CEO Roundtable: Navigating Uncharted Waters
Therapeutic Focus Session 1: The Future of Oncology
Therapeutic Focus Session 2: The Future of CNS
Entrepreneur Roundtable: Exploring New Possibilities